• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索BRAF激酶二聚体中反常激活的分子机制:构象动力学的原子模拟以及变构通讯网络和信号通路的建模

Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.

作者信息

Tse Amanda, Verkhivker Gennady M

机构信息

Department of Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, California, United States of America.

Chapman University School of Pharmacy, Irvine, California, United States of America.

出版信息

PLoS One. 2016 Nov 18;11(11):e0166583. doi: 10.1371/journal.pone.0166583. eCollection 2016.

DOI:10.1371/journal.pone.0166583
PMID:27861609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5115767/
Abstract

The recent studies have revealed that most BRAF inhibitors can paradoxically induce kinase activation by promoting dimerization and enzyme transactivation. Despite rapidly growing number of structural and functional studies about the BRAF dimer complexes, the molecular basis of paradoxical activation phenomenon is poorly understood and remains largely hypothetical. In this work, we have explored the relationships between inhibitor binding, protein dynamics and allosteric signaling in the BRAF dimers using a network-centric approach. Using this theoretical framework, we have combined molecular dynamics simulations with coevolutionary analysis and modeling of the residue interaction networks to determine molecular determinants of paradoxical activation. We have investigated functional effects produced by paradox inducer inhibitors PLX4720, Dabrafenib, Vemurafenib and a paradox breaker inhibitor PLX7904. Functional dynamics and binding free energy analyses of the BRAF dimer complexes have suggested that negative cooperativity effect and dimer-promoting potential of the inhibitors could be important drivers of paradoxical activation. We have introduced a protein structure network model in which coevolutionary residue dependencies and dynamic maps of residue correlations are integrated in the construction and analysis of the residue interaction networks. The results have shown that coevolutionary residues in the BRAF structures could assemble into independent structural modules and form a global interaction network that may promote dimerization. We have also found that BRAF inhibitors could modulate centrality and communication propensities of global mediating centers in the residue interaction networks. By simulating allosteric communication pathways in the BRAF structures, we have determined that paradox inducer and breaker inhibitors may activate specific signaling routes that correlate with the extent of paradoxical activation. While paradox inducer inhibitors may facilitate a rapid and efficient communication via an optimal single pathway, the paradox breaker may induce a broader ensemble of suboptimal and less efficient communication routes. The central finding of our study is that paradox breaker PLX7904 could mimic structural, dynamic and network features of the inactive BRAF-WT monomer that may be required for evading paradoxical activation. The results of this study rationalize the existing structure-functional experiments by offering a network-centric rationale of the paradoxical activation phenomenon. We argue that BRAF inhibitors that amplify dynamic features of the inactive BRAF-WT monomer and intervene with the allosteric interaction networks may serve as effective paradox breakers in cellular environment.

摘要

最近的研究表明,大多数BRAF抑制剂反而可通过促进二聚化和酶反式激活来诱导激酶活化。尽管关于BRAF二聚体复合物的结构和功能研究数量迅速增加,但反常激活现象的分子基础仍知之甚少,且很大程度上仍属假设。在这项工作中,我们使用以网络为中心的方法探索了BRAF二聚体中抑制剂结合、蛋白质动力学和变构信号之间的关系。利用这一理论框架,我们将分子动力学模拟与共进化分析以及残基相互作用网络建模相结合,以确定反常激活的分子决定因素。我们研究了反常诱导剂抑制剂PLX4720、达拉非尼、维莫非尼和一种反常阻断剂抑制剂PLX7904产生的功能效应。BRAF二聚体复合物的功能动力学和结合自由能分析表明,抑制剂的负协同效应和促进二聚化的潜力可能是反常激活的重要驱动因素。我们引入了一种蛋白质结构网络模型,其中共进化残基依赖性和残基相关性动态图谱被整合到残基相互作用网络的构建和分析中。结果表明,BRAF结构中的共进化残基可组装成独立的结构模块,并形成一个可能促进二聚化的全局相互作用网络。我们还发现,BRAF抑制剂可调节残基相互作用网络中全局介导中心的中心性和通信倾向。通过模拟BRAF结构中的变构通信途径,我们确定反常诱导剂和阻断剂抑制剂可能激活与反常激活程度相关的特定信号通路。虽然反常诱导剂抑制剂可能通过一条最佳单一途径促进快速有效的通信,但反常阻断剂可能诱导更广泛的次优和低效通信途径组合。我们研究的核心发现是,反常阻断剂PLX7904可模拟非活性BRAF-WT单体的结构、动力学和网络特征,这可能是逃避反常激活所必需的。这项研究的结果通过提供以网络为中心的反常激活现象原理,使现有的结构-功能实验合理化。我们认为,放大非活性BRAF-WT单体动态特征并干预变构相互作用网络的BRAF抑制剂可能在细胞环境中作为有效的反常阻断剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/79bd9e03772e/pone.0166583.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/376c80653a89/pone.0166583.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/c976a80e1467/pone.0166583.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/906145322f4b/pone.0166583.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/19d468538ccd/pone.0166583.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/148a230ba43b/pone.0166583.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/81e54152261d/pone.0166583.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/60821bf2b078/pone.0166583.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/ac5b5da9d8d5/pone.0166583.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/2e778102f5c5/pone.0166583.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/9eb0533325d1/pone.0166583.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/efd9fb847883/pone.0166583.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/79bd9e03772e/pone.0166583.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/376c80653a89/pone.0166583.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/c976a80e1467/pone.0166583.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/906145322f4b/pone.0166583.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/19d468538ccd/pone.0166583.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/148a230ba43b/pone.0166583.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/81e54152261d/pone.0166583.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/60821bf2b078/pone.0166583.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/ac5b5da9d8d5/pone.0166583.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/2e778102f5c5/pone.0166583.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/9eb0533325d1/pone.0166583.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/efd9fb847883/pone.0166583.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e85/5115767/79bd9e03772e/pone.0166583.g012.jpg

相似文献

1
Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.探索BRAF激酶二聚体中反常激活的分子机制:构象动力学的原子模拟以及变构通讯网络和信号通路的建模
PLoS One. 2016 Nov 18;11(11):e0166583. doi: 10.1371/journal.pone.0166583. eCollection 2016.
2
Molecular dynamics simulations and modelling of the residue interaction networks in the BRAF kinase complexes with small molecule inhibitors: probing the allosteric effects of ligand-induced kinase dimerization and paradoxical activation.BRAF激酶复合物与小分子抑制剂的残基相互作用网络的分子动力学模拟与建模:探究配体诱导的激酶二聚化和反常激活的变构效应。
Mol Biosyst. 2016 Oct 20;12(10):3146-65. doi: 10.1039/c6mb00298f. Epub 2016 Aug 2.
3
Computational Analysis of Residue Interaction Networks and Coevolutionary Relationships in the Hsp70 Chaperones: A Community-Hopping Model of Allosteric Regulation and Communication.热休克蛋白70伴侣中残基相互作用网络与协同进化关系的计算分析:变构调节与通讯的群落跳跃模型
PLoS Comput Biol. 2017 Jan 17;13(1):e1005299. doi: 10.1371/journal.pcbi.1005299. eCollection 2017 Jan.
4
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitors.变构偶联不对称性介导 II 型抑制剂对 BRAF 的反常激活。
Elife. 2024 May 14;13:RP95481. doi: 10.7554/eLife.95481.
5
BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis.BRAF 悖论破解剂 PLX8394、PLX7904 比 BRAF 抑制剂 PLX4720 更能有效针对 BRAFV600Ε CRC 细胞,这通过详细的通路分析得到证实。
Biochim Biophys Acta Mol Basis Dis. 2021 Apr 1;1867(4):166061. doi: 10.1016/j.bbadis.2020.166061. Epub 2020 Dec 29.
6
Dancing through Life: Molecular Dynamics Simulations and Network-Centric Modeling of Allosteric Mechanisms in Hsp70 and Hsp110 Chaperone Proteins.舞动人生:Hsp70和Hsp110伴侣蛋白变构机制的分子动力学模拟与网络中心建模
PLoS One. 2015 Nov 30;10(11):e0143752. doi: 10.1371/journal.pone.0143752. eCollection 2015.
7
Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.c-Abl和c-Src激酶核心蛋白的分子动力学模拟与结构网络分析:从残基中心性捕捉变构机制和通信途径
J Chem Inf Model. 2015 Aug 24;55(8):1645-62. doi: 10.1021/acs.jcim.5b00240. Epub 2015 Aug 12.
8
Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.基于结构的受体酪氨酸激酶ErbB家族激活机制的网络分析:调节脊柱残基是结构稳定性和变构相互作用的全局介质。
PLoS One. 2014 Nov 26;9(11):e113488. doi: 10.1371/journal.pone.0113488. eCollection 2014.
9
Resistance mechanism of the oncogenic β3-αC deletion mutation in BRAF kinase to dabrafenib and vemurafenib revealed by molecular dynamics simulations and binding free energy calculations.通过分子动力学模拟和结合自由能计算揭示致癌性 BRAF 激酶β3-αC 缺失突变对 dabrafenib 和 vemurafenib 的耐药机制。
Chem Biol Drug Des. 2019 Feb;93(2):177-187. doi: 10.1111/cbdd.13399. Epub 2018 Oct 8.
10
Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone.基于集成的细胞周期蛋白依赖性激酶变构相互作用网络和通讯通路建模及刚性分解:区分Hsp90-Cdc37伴侣蛋白的激酶客户
PLoS One. 2017 Nov 2;12(11):e0186089. doi: 10.1371/journal.pone.0186089. eCollection 2017.

引用本文的文献

1
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.一种基于结构的建模方法可识别出针对RAS突变型急性髓系白血病的有效联合用药方案。
bioRxiv. 2025 May 3:2025.04.29.651188. doi: 10.1101/2025.04.29.651188.
2
Mechanism of dimer selectivity and binding cooperativity of BRAF inhibitors.BRAF抑制剂的二聚体选择性和结合协同性机制。
Elife. 2025 Feb 13;13:RP95334. doi: 10.7554/eLife.95334.
3
Mechanism of Dimer Selectivity and Binding Cooperativity of BRAF Inhibitors.BRAF抑制剂的二聚体选择性和结合协同性机制。

本文引用的文献

1
Molecular dynamics simulations and modelling of the residue interaction networks in the BRAF kinase complexes with small molecule inhibitors: probing the allosteric effects of ligand-induced kinase dimerization and paradoxical activation.BRAF激酶复合物与小分子抑制剂的残基相互作用网络的分子动力学模拟与建模:探究配体诱导的激酶二聚化和反常激活的变构效应。
Mol Biosyst. 2016 Oct 20;12(10):3146-65. doi: 10.1039/c6mb00298f. Epub 2016 Aug 2.
2
Probing Allosteric Inhibition Mechanisms of the Hsp70 Chaperone Proteins Using Molecular Dynamics Simulations and Analysis of the Residue Interaction Networks.利用分子动力学模拟和残基相互作用网络分析探究热休克蛋白70伴侣蛋白的变构抑制机制
J Chem Inf Model. 2016 Aug 22;56(8):1490-517. doi: 10.1021/acs.jcim.5b00755. Epub 2016 Aug 1.
3
bioRxiv. 2024 Dec 7:2023.12.12.571293. doi: 10.1101/2023.12.12.571293.
4
Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022.BRAF抑制剂研发历程中的挑战与机遇:2002年至2022年
ACS Omega. 2023 Jul 26;8(31):27819-27844. doi: 10.1021/acsomega.3c00332. eCollection 2023 Aug 8.
5
Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase.利用拆分 Nanoluc 荧光素酶在活细胞中分析 RAS 以及 RAF 和 KSR1 蛋白的药物诱导同型和异型二聚化。
Cell Commun Signal. 2023 Jun 14;21(1):136. doi: 10.1186/s12964-023-01146-9.
6
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAF inhibitors.基于高斯场的3D-QSAR和分子模拟研究,以设计强效嘧啶-磺酰胺杂化物作为选择性BRAF抑制剂。
RSC Adv. 2022 Oct 21;12(46):30181-30200. doi: 10.1039/d2ra05751d. eCollection 2022 Oct 17.
7
Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets.探究 SARS-CoV-2 刺突奥密克戎变异株复合物与宿主受体结合和变构的机制:揭示结合热点在介导上位效应和与变构口袋通讯中的功能作用。
Int J Mol Sci. 2022 Sep 29;23(19):11542. doi: 10.3390/ijms231911542.
8
The mechanism of Raf activation through dimerization.通过二聚化激活Raf的机制。
Chem Sci. 2021 Nov 18;12(47):15609-15619. doi: 10.1039/d1sc03444h. eCollection 2021 Dec 8.
9
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.基于靶向质谱的检测方法可实现受体酪氨酸激酶、MAP 激酶和 AKT 信号通路的多重定量分析。
Cell Rep Methods. 2021 Jul 26;1(3). doi: 10.1016/j.crmeth.2021.100015. Epub 2021 Jun 14.
10
Targeted Therapy for BRAF Mutant Brain Tumors.针对 BRAF 突变脑肿瘤的靶向治疗。
Curr Treat Options Oncol. 2021 Oct 6;22(11):105. doi: 10.1007/s11864-021-00901-9.
Deletion Mutations Keep Kinase Inhibitors in the Loop.缺失突变使激酶抑制剂处于循环中。
Cancer Cell. 2016 Apr 11;29(4):423-425. doi: 10.1016/j.ccell.2016.03.017.
4
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2.致癌性缺失突变在 BRAF、EGFR 和 HER2 中的激活机制。
Cancer Cell. 2016 Apr 11;29(4):477-493. doi: 10.1016/j.ccell.2016.02.010. Epub 2016 Mar 17.
5
A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation.一种具有DFG-out结合模式的新型RAF激酶抑制剂:在BRAF突变肿瘤异种移植模型中具有高效性且不会导致正常组织过度增殖。
Mol Cancer Ther. 2016 Mar;15(3):354-65. doi: 10.1158/1535-7163.MCT-15-0617. Epub 2016 Feb 25.
6
Dancing through Life: Molecular Dynamics Simulations and Network-Centric Modeling of Allosteric Mechanisms in Hsp70 and Hsp110 Chaperone Proteins.舞动人生:Hsp70和Hsp110伴侣蛋白变构机制的分子动力学模拟与网络中心建模
PLoS One. 2015 Nov 30;10(11):e0143752. doi: 10.1371/journal.pone.0143752. eCollection 2015.
7
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes.基于小分子蛋白激酶抑制剂与酶复合物的结构对其进行分类。
Pharmacol Res. 2016 Jan;103:26-48. doi: 10.1016/j.phrs.2015.10.021. Epub 2015 Oct 31.
8
Dynamics-Driven Allostery in Protein Kinases.蛋白激酶中动力学驱动的变构调节
Trends Biochem Sci. 2015 Nov;40(11):628-647. doi: 10.1016/j.tibs.2015.09.002. Epub 2015 Oct 21.
9
Allosteric small-molecule kinase inhibitors.变构小分子激酶抑制剂。
Pharmacol Ther. 2015 Dec;156:59-68. doi: 10.1016/j.pharmthera.2015.10.002. Epub 2015 Oct 24.
10
RAF inhibitors that evade paradoxical MAPK pathway activation.逃避矛盾的 MAPK 通路激活的 RAF 抑制剂。
Nature. 2015 Oct 22;526(7574):583-6. doi: 10.1038/nature14982. Epub 2015 Oct 14.